9 /100
LOW RISK
Score updated Jul 13, 2026

GILD — Gilead Sciences, Inc. Dilution Risk Tracker

Track GILD dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track GILD — Get alerts when the score changes →

As of July 13, 2026, Gilead Sciences, Inc. (GILD) has a DilutionWatch DilutionScore of 9/100, rated LOW dilution risk. Gilead Sciences, Inc. has a market capitalization of $166.90B, 1.24B shares outstanding, 213 institutional holders tracked. Key dilution vectors include approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
0
📊 Float Risk
0
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for GILD.
🔔 Track GILD — Get forecast alerts →

💹 Market Data

Market Cap$166.90B
Shares Outstanding1.24B
Float1.24B
Cash$5.43B
Debt$22.17B
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 5.4% shares (2026Q1 vs prior)
213 institutional holders · 135.53M shares
#1 GILEAD SCIENCES, INC. 31.42M shares
#2 BlackRock, Inc. 15.23M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 7.71M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest25.48M
Days to Cover2.7
% of Float2.1%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Jul 07, 2026
xbrl XBRL CONVERTIBLE Dec 31, 2011
8-K 8K EVENT Apr 28, 2026
4 INSIDER TRANSACTION Apr 16, 2026
4 INSIDER TRANSACTION Apr 16, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for GILD Shareholders

Gilead Sciences, Inc. (GILD) has a DilutionScore of 9/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for GILD shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for GILD in real-time, scanning EDGAR every 60 seconds. Recent 8-K filings are present; material events disclosures can sometimes precede or accompany capital raises. The DilutionWatch screener shows real-time score changes for GILD alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track GILD Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking GILD — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for GILD
📊 GILD FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 GILD Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.